Lessons Learned: Role of Influenza Vaccine Production, Distribution, Supply, and Demand-What It Means for the Provider

American Journal of Medicine

Volumn 121, Issue 7 SUPPL. 2, 2008, Pages

  Orenstein, Walter A ^a   Schaffner, William ^b  

^a EMORY UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Demand; Influenza; Supply; Vaccine production

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; DECISION MAKING; DRUG INDUSTRY; DRUG MARKETING; DRUG USE; EVOLUTIONARY ADAPTATION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; PRIORITY JOURNAL; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

DRUG COMPOUNDING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; SEASONS; UNITED STATES; VACCINATION;

EID: 45749102809     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.05.004     Document Type: Article

References (30)

1. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
2. Thompson W.W., Shay D.K., Weintraub E., et al. Influenza-associated hospitalizations in the United States. JAMA. 292 (2004) 1333-1340
3. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56 RR06 (2007) 1-54
4. Centers for Disease Control and Prevention (CDC). CDC's advisory committee recommends influenza vaccination for children 6 months through 18 years of age [press release]. http://www.cdc.gov/media/pressrel/2008/r080227.htm Accessed May 29, 2008
5. Mason D. A vaccine supply update for the US marketPresented at the National Vaccine Advisory Committee Meeting; Washington, DC: June 3, 2003 [PowerPoint slide presentation]. www.hhs.gov/nvpo/meetings/jun2003/mason-s.ppt Accessed February 22, 2008
6. Orenstein W.A., Douglas R.G., Rodewald L.E., and Hinman A.R. Immunizations in the United States: success, structure, and stress. Health Aff (Millwood) 24 (2005) 599-610
7. Layton C., Robinson T., and Honeycutt A. Influenza Vaccine Demand: The Chicken and the Egg, Issue Brief, 2005. Prepared for the Assistant Secretary for Planning and Evaluation, US Dept of Health and Human Services, under Contract No. 100-03-0001 [report]. Research Triangle Park, NC: RTI International. RTI Project No. 0208665.001. http://aspe.hhs.gov/pic/fullreports/06/8476-4.doc Accessed March 6, 2008
8. Rodewald L.E., Orenstein W.A., Mason D.D., and Cochi S.L. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention. Clin Infect Dis 42 suppl 3 (2006) S104-S110
9. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 51 RR03 (2002) 1-31
10. Danzon P.M., Pereira N.S., and Tejwani S.S. Vaccine supply: a cross-national perspective. Health Aff (Millwood) 24 (2005) 706-717
11. Gerberding J.L. US influenza supply and preparations for the future. Testimony before the Committee on Government Reform, US House of Representatives. February 10, 2005. http://www.hhs.gov/asl/testify/t050210b.html Accessed.
12. Fishbein D.B., Fontanesi J., Kopald D., et al. Why do not patients receive influenza vaccine in December and January?. Vaccine 24 (2006) 798-802
13. Fiore A. Influenza activity in the United States, February 2007. Presented at the Advisory Committee on Immunization Practices, October 23, 2007, Atlanta, Georgia. http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-Oct07/93-flu.pdf Accessed May 28, 2008
14. US Department of Health and Human Services. Healthy People 2010 influenza immunization goals. http://www.healthypeople.gov/document/html/objectives/14-29.htm Accessed March 5, 2008
15. Coleman M., Sangrujee N., Zhou F., and Chu S. Factors affecting US manufacturers' decision to produce vaccines. Health Aff (Millwood) 24 (2005) 635-642
16. Betts R.F. Influenza virus. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglass, and Bennett's Principles and Practice of Infectious Diseases. 4th ed. (1994), Churchill Livingstone, New York 1546-1567
17. Layton C., and Lenfestey N. Influenza Vaccine Manufacturing, Issue Brief, October 2005. Prepared for the Assistant Secretary for Planning and Evaluation, US Dept of Health and Human Services, under Contract No. 100-03-0001 [report]. Research Triangle Park, NC: RTI International. RTI Project No. 0208665.001. http://aspe.hhs.gov/pic/fullreports/06/8476-2.doc Accessed March 6, 2008
18. Bridges C.B., Thompson W.W., Meltzer M.I., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 284 (2000) 1655-1663
19. Bridges C.B., Katz J.M., Levandowski R.A., and Cox N.J. Inactivated influenza vaccines. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines. 5th ed. (2008), Elsevier, Philadelphia 259-290
20. Belshe R.B., Walker R., Stoddard J., et al. Influenza vaccine-live. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines. 5th ed. (2008), Elsevier, Philadelphia 291-309
21. Wallace G.S. Vaccine supply update & programmatic implications. Presented at the Advisory Committee on Immunization Practices, February 27, 2008; Atlanta [PowerPoint slide presentation]. http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-feb08/23-vac-supply.pdf Accessed May 28, 2008
22. Jones T.F., Ingram L.A., Craig A.S., and Schaffner W. Determinants of influenza vaccination, 2003-2004: shortages, fallacies and disparities. Clin Infect Dis 39 (2004) 1824-1828
23. Hinman A.R., Orenstein W.A., and Rodewald L. Financing immunizations in the United States. Clin Infect Dis 38 (2004) 1440-1446
24. Institute of Medicine. Financing Vaccines in the 21st Century: Assuring Access and Availability (2003), The National Academies Press, Washington, DC. http://www.iom.edu/?id=14451&redirect=0 Accessed March 5, 2008
25. Adler G.S. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged ≥65 years: United States, 1991-2002. MMWR Morb Mortal Wkly Rep 53 (2004) 1012-1015
26. Poland G.A., Tosh P., and Jacobson R.M. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 23 (2005) 2251-2255
27. National Influenza Vaccine Summit. Minutes of meeting; January 24-25, 2006; Atlanta, GA. http://www.ama-assn.org/ama1/pub/upload/mm/36/summit_minutes.pdf Accessed March 5, 2008
28. Belshe R.B. Translational research on vaccines: influenza as an example. Clin Pharmacol Ther 82 (2007) 745-749
29. Cox M.M. Progress on baculovirus-derived influenza vaccines. Curr Opin Mol Ther 10 (2008) 56-61
30. Abramson J.S., Neuzil K.M., and Tamblyn S.E. Annual universal influenza vaccination: ready or not?. Clin Infect Dis 42 (2006) 132-135